Assistant Professor, Medicine, Massachusetts General Hospital, Harvard Medical School. Medical Director, Trial Design, Harvard Clinical Research Institute.
Cardiology
Dr. Robert W. Yeh, MD
|
|
Give Review
Dr. Robert W. Yeh practices Cardiology. He graduated from Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received 2 awards: "Fellow (FACC)" and "Fellow (FAHA)". Robert is also published. He has 88 publications published. The lastest publication: "Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.' He accepts Medicare.
Publications
- Hard questions for mobile technology in cardiology.
- Incidence and predictors of incomplete revascularization in a contemporary cohort.
- Angina Severity, Depression, and Response to Percutaneous Revascularization in Patients With Chronic Total Occlusion of Coronary Arteries.
- Letter by Wasfy et al Regarding Article, "Facility Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention: In...
- Effect of Previous Failure on Subsequent Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention (from a Contemporary Multicenter Registry).
- Causes of late mortality with dual antiplatelet therapy after Coronary stents.
- Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
- Mortality risk with dual antiplatelet therapy?
- Application and outcomes of a hybrid approach to chronic total occlusion percutaneous Coronary intervention in a contemporary multicenter US registry.
- Population trends in rates of Coronary revascularization.
- Dual antiplatelet platelet therapy duration following Coronary stenting.
- Benefits and Risks of Extended Duration Dual Antiplatelet Therapy after PCI in Patients With and Without Acute Myocardial Infarction.
- Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy.
- Antiplatelet therapy duration following bare metal or drug-eluting Coronary stents: the dual antiplatelet therapy randomized clinical trial.
- Association between public reporting of outcomes with procedural management and mortality for patients with Acute myocardial infarction.
- The Data Extraction and Longitudinal Trend Analysis Network Study of Distributed Automated Postmarket Cardiovascular Device Safety Surveillance.
- Public reporting and Coronary revascularization: risk and benefit.
- Evaluating the Generalizability of a Large Streamlined Cardiovascular Trial: Comparing Hospitals and Patients in the Dual Antiplatelet Therapy Study Versus the Nationa...
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents.
- Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.
- Surgical Ineligibility and Mortality Among Patients with Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
- Culprit only, multivessel, or staged multivessel intervention in STEMI: New insights or insurmountable methodologic obstacles?
- The Challenges of Success: Maintaining Access to High Quality PCI in the Face of Declining Procedural Volumes.
- Delay in reperfusion with transradial percutaneous Coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable?
- Public Reporting of PCI Outcomes: For Better or for Worse.
- Association Between Operator Procedure Volume and Patient Outcomes in Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
- Defining unavoidable delays in primary percutaneous Coronary intervention: discordance among patients excluded from National Cardiovascular Quality Registries.
- Usefulness of Postmarket Studies to Evaluate Long-Term Safety of Coronary Eluting Stents (from the ENDEAVOR and PROTECT Programs).
- Adherence to Dual Antiplatelet Therapy After Coronary Stenting: A Systematic Review.
- Population trends from 2000-2011 in nuclear Myocardial perfusion imaging use.
- Usefulness of the Seattle Heart failure model to identify adults with congenital Heart disease at high risk of poor outcome.
- Causes of short-term readmission after percutaneous Coronary intervention.
- Cardiovascular event risk after noncardiac surgery.
- Comparative effectiveness of commonly used devices for Carotid artery stenting: an NCDR Analysis (National Cardiovascular Data Registry).
- High-risk percutaneous Coronary intervention in the era of public reporting: clinical and ethical considerations in the care of an elderly patient with critical left m...
- Comparison of Transradial Versus Transfemoral Percutaneous Coronary Intervention in Routine Practice: Evidence for the Importance of "Falsification Hypotheses" in Obse...
- Impact of Academic Year Timing on PCI Outcomes at Training Institutions.
- Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly.
- Reporting Trends and Outcomes in ST-Segment-Elevation Myocardial Infarction National Hospital Quality Assessment Programs.
- Frequency of the Use of Low- Versus High-Dose Aspirin in Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (from the Dual Antiplatelet Therapy Study).
- Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive Disease: A meta-analysis and critical examination of current methodologies.
- Cardiovascular Care Facts: A Report from the National Cardiovascular Data Registry - 2011.
- Strategies for Postmarketing Surveillance of Drugs and Devices in Patients with ESRD Undergoing Dialysis.
- Features of Coronary Plaque in Patients with Metabolic Syndrome and Diabetes Mellitus Assessed by 3-vessel Optical Coherence Tomography.
- A combined epidemiologic and metabolomic approach improves CKD prediction.
- A prediction model to identify patients at high risk for 30-day readmission after percutaneous Coronary intervention.
- Unprotected Carotid artery stenting in modern practice.
- Hemorrhagic and Ischemic Outcomes After Bivalirudin Versus Unfractionated Heparin During Carotid Artery Stenting: A Propensity Score Analysis From the NCDR.
- Caesarian Dissection: a case of chest pain and dyspnea during delivery.
- Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status.
- Model Feedback in Bayesian Propensity Score Estimation.
- Comparison of nonculprit Coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study.
- Pre-procedural risk quantification for Carotid stenting using the CAS score: a report from the NCDR CARE Registry.
- Another View of Personalized Medicine: Optimizing Stent Selection on the Basis of Predicted Benefit in Percutaneous Coronary Intervention.
- Management Strategy in 249 Consecutive Patients With Obstructive Hypertrophic Cardiomyopathy Referred to a Dedicated Program.
- Comparison of Incidence and Time Course of Neoatherosclerosis Between Bare Metal Stents and Drug-Eluting Stents Using Optical Coherence Tomography.
- Non-Culprit Plaques in Patients with Acute Coronary Syndromes (ACS) Have More Vulnerable Features Compared to Those with Non-ACS: A 3-Vessel Optical Coherence Tomograp...
- Sources of Hospital Variation in Short-Term Readmission Rates After Percutaneous Coronary Intervention.
- Choosing Methods to Minimize Confounding in Observational Studies: Do the Ends Justify the Means?
- Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention.
- Surgical candidacy and selection biases in nonemergent left main stenting implications for observational studies.
- Clinical factors and echocardiographic techniques related to the presence, size, and location of acoustic windows for leadless cardiac pacing.
- Accounting for the mortality benefit of drug-eluting stents in percutaneous Coronary intervention: a comparison of methods in a retrospective cohort study.
- Do postmarketing surveillance studies represent real-world populations?: a comparison of patient characteristics and outcomes after Carotid artery stenting.
- Anticoagulant agents in Acute coronary syndromes.
- Clinical referral patterns for Carotid artery stenting versus Carotid endarterectomy: results from the Carotid Artery Revascularization and Endarterectomy Registry.
- Takotsubo cardiomyopathy complicated by cardiac tamponade: classic hemodynamic findings with a new Disease.
- Population trends in the incidence and outcomes of Acute myocardial infarction.
- Rethinking the epidemiology of Acute myocardial infarction: challenges and opportunities.
- Calcium-triggered short-coupled polymorphous ventricular tachycardia.
- Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with Acute coronary syndromes.
- Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial Disease.
- Episodic ventricular pacing with intact atrioventricular nodal function in a DDDR device: what is the rhythm and how can it be prevented?
- Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with Acute coronary syndromes.
- Analysis of cardiac dimensions, mass and function in Heart transplant recipients using 64-slice multi-detector computed tomography.
- Comparison of sixty-four-slice multidetector computed tomographic Coronary angiography to Coronary angiography with intravascular ultrasound for the detection of trans...
- Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
- Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
- Argatroban: update.
- Clinical preventability of 30-day readmission after percutaneous Coronary intervention.
- Clinical prediction model suitable for assessing hospital quality for patients undergoing Carotid endarterectomy.
- Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous Coronary in...
- Inadvertent femoral endarterectomy: a complication from a suture-based vascular closure device.
- Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period.
- What is the optimal anticoagulation level with argatroban during percutaneous Coronary intervention?
- Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
- Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.
Schools
Harvard Medical School
Massachusetts General Hospital
University Of California San
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardioversion, Elective
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Network Health
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Fellow (FACC)
- Fellow (FAHA)
Education
-
Harvard Medical School -
UCSF -
Massachusetts General Hospital
Hospital
-
Massachusetts General Hospital -
Beth Israel Deaconess Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154302057 |
| Last Name Of The Provider | YEH |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Prem S. Subramaniyam, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan K. Kaple, MD |
|
|
Dr. Robert M. Gallagher, MD |
|
|
Dr. Klaus A. Tiroch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily D. Slater, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Maisel, MD |
|
|
Dr. Peter Ganz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia Tung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter M. Kang, MD |
|
|
Dr. Jiwon Kim, MD |
|
|
Dr. Joshua R. Silverstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephan B. Danik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory A. Imbrie, MD |
|
|
Dr. Mark N. Nallaratnam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madhusudan P. Thakur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer E. Ho, MD
This Doctor is OpenDoctor Recommended.
|